aTYR PHARMA (ATYR) Return on Equity [ROE] (2015 - 2026)
aTYR PHARMA (ATYR) reported Return on Equity [ROE] of -114.17% for Q2 2026, down 25.03 percentage points from -89.14% a year earlier and down 2.31 percentage points from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, aTYR PHARMA posted Return on Equity [ROE] of -107.96%, down 28.09 percentage points from FY2024.
- Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -46.15 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -79.88% in FY2024 (-17.56 pp), -62.31% in FY2023 (-12.05 pp), -50.27% in FY2022 (-2.22 pp) and -48.04% in FY2021 (+13.77 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2015.
- Year over year, Return on Equity [ROE] has now declined in each of the last ten quarters, with an average year-over-year change of -24.51 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q1 2022 (a gain of 24.68 percentage points); the low point was Q3 2024 (a drop of 44.82 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -111.86% (Q1 2026), -100.36% (Q4 2025) and -97.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.06 Bn | 1,139.65 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 634.89 Bn | 553.42 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | - |
| 4 | Merck | 377.44 Bn | 331.82 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 303.91 Bn | 267.90 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.03 Bn | 240.72 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.88 Bn | 197.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.57 Bn | 119.21 Bn | 10.94 Bn | 4.97% |
| 10 | aTYR PHARMA | 17.36 Mn | -275.46 Mn | - | -114.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -114.17% |
| Mar 31, 2026 | -111.86% |
| Dec 31, 2025 | -100.36% |
| Sep 30, 2025 | -97.01% |
| Jun 30, 2025 | -89.14% |
| Mar 31, 2025 | -87.66% |
| Dec 31, 2024 | -94.87% |
| Sep 30, 2024 | -87.08% |
| Jun 30, 2024 | -69.88% |
| Mar 31, 2024 | -61.72% |
| Dec 31, 2023 | -53.42% |
| Sep 30, 2023 | -42.26% |
| Jun 30, 2023 | -41.77% |
| Mar 31, 2023 | -49.88% |
| Dec 31, 2022 | -61.15% |
| Sep 30, 2022 | -56.75% |
| Jun 30, 2022 | -44.15% |
| Mar 31, 2022 | -37.37% |
| Dec 31, 2021 | -29.82% |
| Sep 30, 2021 | -38.11% |
API Access
aTYR PHARMA Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();